Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies

  • Study examines association of genetic variants with cognitive impairment

  • Hospice use linked to fewer depressive symptoms for surviving spouses

  • Where there's a will ? well, there's another way

  • Babies can think before they can speak

  • Road traffic noise linked to heightened risk of midriff bulge

  • Neuroscientists reveals autism's 'noisy' secret: 3-D simulator reveals inner workings of the autistic brain

  • Honesty can keep companies' stock prices up during hard times

  • You?re driving yourself to burnout, literally

  • Communication made easier for children with cerebral palsy

  •